Vir Biotechnology, Inc. — Institutional Ownership
Which tracked institutions hold VIR, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
26
Funds holding
$398048038
Total value held
Buying
22 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $161265028 | 17998329 | +1668226 | +10.22% |
| 2 | Gsk Plc | $76616548 | 8550954 | — | NEW BUY |
| 3 | State Street Corp | $63984202 | 7141094 | +911539 | +14.63% |
| 4 | Goldman Sachs Group Inc | $29122034 | 3250227 | +1681323 | +107.17% |
| 5 | Morgan Stanley | $25573682 | 2854205 | +175060 | +6.53% |
| 6 | Northern Trust Corp | $8829496 | 985435 | +136966 | +16.14% |
| 7 | Bank Of America Corp /De/ | $8653694 | 965814 | +34906 | +3.75% |
| 8 | Bank Of New York Mellon Corp | $5233058 | 584047 | +38490 | +7.06% |
| 9 | Principal Financial Group Inc | $4907867 | 547753 | +97158 | +21.56% |
| 10 | Ameriprise Financial Inc | $3539541 | 395038 | -336269 | -45.98% |
| 11 | Invesco Ltd. | $2446359 | 405698 | -12258 | -2.93% |
| 12 | Citigroup Inc | $1877060 | 311287 | -12238 | -3.78% |
| 13 | Nomura Holdings Inc | $1274470 | 142240 | — | NEW BUY |
| 14 | Barclays Plc | $1207772 | 134796 | — | NEW BUY |
| 15 | Prudential Financial Inc | $1034002 | 115402 | -166140 | -59.01% |
| 16 | Wells Fargo & Company/Mn | $635632 | 105412 | +29967 | +39.72% |
| 17 | Janus Henderson Group Plc | $490636 | 54789 | — | NEW BUY |
| 18 | Bank Of Montreal /Can/ | $346188 | 38637 | — | NEW BUY |
| 19 | Sei Investments Co | $315412 | 35202 | — | NEW BUY |
| 20 | Fifth Third Bancorp | $235863 | 26324 | +24471 | +1320.62% |
| 21 | Royal Bank Of Canada | $138000 | 15355 | — | NEW BUY |
| 22 | Raymond James Financial Inc | $110503 | 12333 | — | NEW BUY |
| 23 | Pnc Financial Services Group, Inc. | $101606 | 11340 | +918 | +8.81% |
| 24 | Marex Group Plc | $98560 | 11000 | — | NEW BUY |
| 25 | Us Bancorp \De\ | $10573 | 1180 | +28 | +2.43% |
| 26 | Amalgamated Financial Corp. | $252 | 9803 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.